The value of fibroblast growth factor 21 in health and pathology
Open Access
- 5 October 2025
- journal article
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 40 (3) , 28-35
Abstract
The article presents current ideas about the role of fibroblast growth factor 21 (FGF21) in the regulation of carbohydrate and lipid metabolism, as well as its contribution to the development of systemic inflammation in rheumatoid arthritis, both in laboratory animals and in humans. The classification of the fibroblast growth factor family, regulation of expression and receptor apparatus is considered. Positive effects of FGF21 have been noted in the form of normalization of carbohydrate and lipid metabolism, body weight; drugs analogues of FGF21 have proven themselves well as a therapeutic agent for the treatment of metabolic complications such as diabetes and fatty liver disease. At the same time, data are provided on the connection between elevated levels of FGF21 in blood serum and a number of pathological conditions, such as type 2 diabetes mellitus, coronary heart disease, obesity, non-alcoholic fatty liver disease, and end-stage renal failure. The facts about the controversial role of FGF21 against the background of systemic inflammation in patients with rheumatoid arthritis (RA) are reviewed. On the one hand, FGF21 may have a protective effect in patients with RA; on the other hand, serum FGF21 can be considered as a predictor of future decline in functional status and a potential marker for the progression of systemic inflammation in patients with RA. The prospects for using FGF21 for therapeutic purposes are assessed.Keywords
This publication has 49 references indexed in Scilit:
- Adipokines, adiposity, and atherosclerosisCellular and Molecular Life Sciences, 2022
- Receptors | Peroxisome Proliferator-Activated Receptors2021
- Fibroblast Growth Factor-21 Ameliorates Rheumatoid Arthritis by Maintaining Articular IntegrityInternational Journal of Peptide Research and Therapeutics, 2020
- Baicalein stimulates fibroblast growth factor 21 expression by up-regulating retinoic acid receptor-related orphan receptor α in C2C12 myotubesBiomedicine & Pharmacotherapy, 2019
- Pegbelfermin (BMS‐986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 StudyObesity, 2018
- Fibroblast growth factor 21 ameliorates vascular calcification by inhibiting osteogenic transition in vitamin D3 plus nicotine-treated ratsBiochemical and Biophysical Research Communications, 2018
- FGF21 exerts comparable pharmacological efficacy with Adalimumab in ameliorating collagen-induced rheumatoid arthritis by regulating systematic inflammatory responseBiomedicine & Pharmacotherapy, 2017
- Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stressDiabetologia, 2014
- βKlotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and MetabolismCell Metabolism, 2012
- Inhibition of Growth Hormone Signaling by the Fasting-Induced Hormone FGF21Cell Metabolism, 2008